Home / Recalls / Torrent Pharma Inc. / D-1317-2020

D-1317-2020 Class II Terminated

Recalled by Torrent Pharma Inc. — Basking Ridge, NJ

Recall Details

Product Type
Drugs
Report Date
June 10, 2020
Initiation Date
May 11, 2020
Termination Date
August 10, 2022
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
6228 Bottles

Product Description

Carbamazepine Tablets, USP 200 mg, packaged in a 500-count bottle, Rx only, Manufactured by: Torrent Pharmaceuticals Ltd, Bharuch 392130, India; Manufactured for: Torrent Pharma Inc., Basking Ridge, NJ 07920, NDC 13668-268-05

Reason for Recall

Failed Dissolution Specifications

Distribution Pattern

USA Nationwide and Puerto Rico

Code Information

Lot #: 4FF4F001, Exp 1/2023

Other recalls by Torrent Pharma Inc.

  • D-0456-2025 Class II — Fluoxetine Tablets, USP, 20 mg, 28-count Carton (4x7 Unit-dose), Manufactured by (May 27, 2025)
  • D-0455-2025 Class II — Fluoxetine Tablets, USP, 20 mg, 30-count bottle, Rx only, Manufactured by: TORR (May 27, 2025)
  • D-0852-2022 Class II — Pantoprazole Sodium Delayed-Release Tablets, USP, 20 mg, Rx Only, 90 tablets per (April 11, 2022)
  • D-0365-2022 Class II — Carbamazepine Tablets, USP 200 mg 100 Tablets Rx only NDC 13668-268-01 Manufactu (December 2, 2021)
  • D-0285-2022 Class III — Telmisartan and Hydrochlorothiazide Tablets, USP, 40 mg/12.5 mg, 30 count bottle (December 1, 2021)
  • D-0166-2021 Class I — Anagrelide Capsules, USP 1 mg, 100 capsules, Rx only, Manufactured in India for: (November 25, 2020)
  • D-0124-2020 Class II — Losartan Potassium/ Hydrochlorothiazide Tablets, USP 100mg/25mg, 90 tablets per (September 19, 2019)
  • D-0123-2020 Class II — Losartan Potassium /Hydrochlorothiazide Tablets, USP 50mg/12.5mg, 90 tablets per (September 19, 2019)
  • D-0122-2020 Class II — Losartan Potassium Tablets, USP 100 mg, [90 or 1000] tablets per bottle, Rx Only (September 19, 2019)
  • D-0121-2020 Class II — Losartan Potassium Tablets, USP 50mg, 1000 tablets per bottle, Rx Only, Manufact (September 19, 2019)